WAM
ASXC

Wealthspire Advisors (Maryland)’s Asensus Surgical, Inc. ASXC Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-385
Closed -$12K – 2164
2019
Q1 		$12K Hold
385
– – ﹤0.01% 1472
2018
Q4 		$11K Buy
+385
New +$17.5K ﹤0.01% 1444
2016
Q2 		– Sell
-18
Closed -$1K – 1825
2016
Q1 		$1K Buy
+18
New +$771 ﹤0.01% 1686

Other funds holding ASXC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s ASXC Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Asensus Surgical, Inc. (ASXC) in Q2 2019, closing a stake of 385 shares — an estimated $12K sold.

Wealthspire Advisors (Maryland) first reported a position in ASXC in Q1 2016 and held it in 3 quarters. The position peaked at $12K in Q1 2019. 141 funds tracked by Wall St. Rank hold ASXC as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Asensus Surgical, Inc. position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 385 Asensus Surgical, Inc. shares in Q2 2019, an estimated $12K.
  • Wealthspire Advisors (Maryland) first reported a position in Asensus Surgical, Inc. in Q1 2016 and held it in 3 quarters.
  • Wealthspire Advisors (Maryland)'s Asensus Surgical, Inc. position peaked at $12K in Q1 2019.
  • 141 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.